FdaApplication
ANDA 214025
Identifiers
- fda_app_no: ANDA214025
Properties
| Property | Value |
|---|---|
| applicant_name | NOVAST LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2025-10-15 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CONJUGATED ESTROGENS | ESTROGENS, CONJUGATED | 0.45MG | TABLET;ORAL |
| CONJUGATED ESTROGENS | ESTROGENS, CONJUGATED | 0.3MG | TABLET;ORAL |
| CONJUGATED ESTROGENS | ESTROGENS, CONJUGATED | 0.625MG | TABLET;ORAL |
3 products